Concepedia

Antonio Ramos‐Montoya

AR

Statistics

Publications

35

Citations

3.3K

H-Index

27

Active since

2004

Affiliations

University of Cambridge(Current)

Addenbrooke's Hospital

Cancer Research UK

Cancer Research UK Cambridge Center

AstraZeneca (United Kingdom)

Antonio Ramos‐Montoya is an author at University of Cambridge specializing in medicine, cell biology, and systems biology.

ORCID

Top concepts

Publications per year

2004–2022

35

Publications

35

The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

Charles Massie, Andy G. Lynch, Antonio Ramos‐Montoya et al. · The EMBO Journal · 2011 · 627 citations · Full text

, , +7

The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man

Naomi L. Sharma, Antonio Ramos‐Montoya, Vincent Zecchini et al. · Cancer Cell · 2012 · 407 citations · Full text

, , +8

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity

Jacqueline H. L. Fok, Antonio Ramos‐Montoya, Mercedes Vázquez–Chantada et al. · Nature Communications · 2019 · 327 citations · Full text

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

Helen Ross‐Adams, Alastair Lamb, Mark Dunning et al. · EBioMedicine · 2015 · 317 citations · Full text

Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells

Rebecca L. Lloyd, Paul W.G. Wijnhoven, Antonio Ramos‐Montoya et al. · Oncogene · 2020 · 179 citations · Full text

Rows per page

1–5 of 35